Search results
Results from the WOW.Com Content Network
PCA3 has been shown to be useful to predict the presence of malignancy in men undergoing repeat prostate biopsy. [9] [10] This means that it could be useful clinically for a patient for whom digital rectal examination and PSA suggest possible prostate cancer, but the first prostate biopsy returns a normal result. This occurs in approximately 60 ...
Prostate cancer antigen 3 is a urine test that detects the overexpression of the PCA3 gene, an indicator of prostate cancer. [32] [46] [47] [44] ConfirmMDx is performed on tissue taken during a prostate biopsy. The test identifies men with clinically significant prostate cancer who would benefit from further testing and treatment.
Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), P-30 antigen, is a glycoprotein enzyme encoded in humans by the KLK3 gene.PSA is a member of the kallikrein-related peptidase family and is secreted by the epithelial cells of the prostate gland in men and the paraurethral glands in women.
“This means thousands of men avoiding unnecessary, invasive tests and spared the worry of an unnecessary diagnosis.” Allan Roper, 73, was diagnosed with prostate cancer in 2015 but has been ...
They used colon cancer cells and blood samples from 16 men over 50 who, due to lifestyle choices, had a higher risk of colon cancer. "Therefore, being active twice daily, instead of once, could ...
Research conducted by Indiana University's Center for Sexual Health showed that using lube makes it 50% easier for both men and women to orgasm. And it makes sense, too: according to Elist, lube ...
Prostate cancer is the most diagnosed cancer in men in over half of the world's countries, and the leading cause of cancer death in men in around a quarter of countries. [91] Prostate cancer is rare in those under 40 years old, [92] and most cases occur in those over 60 years, [2] with the average person diagnosed at 67. [93]
For men over 64 with prostate cancer limited to the pelvis, using fewer, larger doses of radiation (hypofractionation) results in similar overall survival rates. [28] The risk of dying from prostate cancer or having acute bladder side effects may be similar to that of longer radiation treatment. [ 28 ]